Myung Koo Kang
Dong-a University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Myung Koo Kang.
World Journal of Surgical Oncology | 2013
Sun Yi Choi; Heon-Soo Park; Myung Koo Kang; Dong Kun Lee; Kang Dae Lee; Hyoung Shin Lee; Sung Won Kim; Eun Nam Lee; Jong Chul Hong
BackgroundThe BRAFV600E mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAFV600E mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear.MethodsWe performed a retrospective review of 101 patients who underwent surgery for PTMC. We studied the prevalence of the BRAFV600E mutation. The associations between the BRAFV600E mutation and clinicopathologic characteristics were analyzed.ResultsThe BRAFV600E mutation was observed in 72 patients (71.3%). There was no statistically significant correlation in age, gender, multifocality, extrathyroidal extension, presence of Hashimoto thyroiditis, and lymph node metastasis between the BRAFV600E mutant group and wild group.ConclusionsThe BRAFV600E mutation is not significantly associated with prognostic factors in PTMC.
Annals of Otology, Rhinology, and Laryngology | 2015
Dong Kun Lee; Ji Won Seo; Heon Soo Park; Myung Koo Kang; Ae Lan Jang; Joon Hyung Lee; Jong Chul Hong
Objective: Ethanol ablation has been known as an effective, easy, and safe treatment of cystic thyroid lesions. The objective of the present study was to evaluate efficacy of ethanol ablation as a minimally invasive management of thyroglossal duct cyst (TGDC). Methods: Between January 2012 and July 2013, 9 TGDC patients were diagnosed and treated with ethanol ablation. We evaluated the treatment outcomes with the change of volume reduction and the improvement of symptomatic and cosmetic complaints and complications. Results: Initial mean tumor volume was 8.9 mL (range, 0.2-36.9 mL) in ultrasonography. The mean number of the treatment sessions was 1.7 (range, 1-3 sessions). At last follow-up, the mean volume of the treated thyroglossal duct cyst decreased significantly from 8.9 mL to 1.9 mL (P = .019; volume reduction rate = 76.6%). Treatment success rate was 77.8% (7/9). Mean symptoms and cosmetic-grading scores improved from 5.2 to 3.1 and from 5.3 to 3.1 (P = .062). No significant complications were observed during follow-up. Conclusion: Ethanol ablation is a feasible and convenient procedure without surgical scars and hospitalization for TGDC patients. Favorable outcomes can be achieved without significant complications.
Annals of Otology, Rhinology, and Laryngology | 2014
Kyung Wook Heo; Myung Koo Kang; Jae Yeong Park
Objectives: Surgical procedures for chronic ear disease can be grossly divided into two tympanoplasty procedures: canal wall–up and canal wall–down (CWD) mastoidectomies. The choice depends on the surgeon’s preference. Epitympanoplasty with mastoid obliteration (EMO) has shown postoperative results similar to those of CWD mastoidectomy with long-term follow-up. In this study, we compared the outcomes of EMO and CWD mastoidectomy in preoperatively sclerotic mastoid cavities with cholesteatoma, chronic otitis media with poor eustachian tube function, or adhesive otitis media. The operations were performed by the same surgeons in order to eliminate any effect of surgeon preference on the surgical outcomes. Methods: We reviewed the medical records of patients who underwent tympanoplasty with EMO (EMO group) or CWD mastoidectomy (CWD group) and followed them for more than 28 months. The postoperative outcomes were analyzed and compared. Results: The EMO and CWD groups comprised 132 and 110 ears, respectively. In both groups, the air-bone gaps were significantly reduced after operation. The relapse rates of the groups were similar. Cavity problems were the most common complication in the CWD group. The overall complication rate in the EMO group was significantly lower than that in the CWD group (p = 0.044). Conclusions: Epitympanoplasty with mastoid obliteration can be considered an alternative procedure to CWD mastoidectomy in patients with preoperatively sclerotic mastoid cavities. It gives similar surgical results and has fewer complications.
Clinical Otolaryngology | 2017
Jong Chul Hong; Ji Won Seo; Ae Lan Jang; Sung Hwan Suh; M.G. Pak; S.H. Han; Y.J. Park; D.K. Lee; Heon Soo Park; Myung Koo Kang
This study was designed to evaluate the usefulness of intra‐operative frozen section for the evaluation of microscopic extrathyroidal extension (ETE) in papillary thyroid carcinoma (PTC).
Clinical Otolaryngology | 2017
Ji Won Seo; Ae Lan Jang; Sung Hwan Suh; Heon Soo Park; Myung Koo Kang; Jong Chul Hong
This study is designed to determine the clinical predictors of malignancy in the atypia of undetermined significance (AUS) category resulted from thyroid fine needle aspiration (FNA).
Korean Journal of Otorhinolaryngology-head and Neck Surgery | 2013
Gi Geun Kang; Myung Koo Kang; Heon Soo Park; Jong Chul Hong
Archive | 2011
Ji Sang Park; Jong Chul Hong; Byung Gun Park; Myung Koo Kang
Korean Journal of Otorhinolaryngology-head and Neck Surgery | 2010
Seung Hyun Chung; Jong Chul Hong; Heon Soo Park; Myung Koo Kang
Korean Journal of Otorhinolaryngology-head and Neck Surgery | 2016
Jae Hoon Lee; Si Won Yoon; Heon Soo Park; Myung Koo Kang; Joon Hyung Lee; Ae Lan Jang; Jong Chul Hong
The Korean Journal of Blood Transfusion | 2015
Bo Ram Kim; Kyeong Hee Kim; Hyeon-Ho Lim; Byoung Gwon Kim; Myung Koo Kang; Tea Ok Cha